# MiniMed Group (MMED) — Analyst Forecast

MMED · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mmed/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 12 | 3 | 1 | 16 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $21.00 | $25.91 | $29.00 | 11 |

Last price $18.00 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | Jefferies | Initiated Coverage | Hold | $22.00 |
| Oct 8, 2026 | Mizuho | Maintained | Outperform | $28.00 |
| Oct 7, 2026 | Barclays | Initiated Coverage | Equal-Weight | $22.00 |
| Sep 24, 2026 | Truist Securities | Initiated Coverage | Buy | $29.00 |
| Sep 3, 2026 | Morgan Stanley | Maintained | Overweight | $21.00 |
| Sep 2, 2026 | B of A Securities | Maintained | Buy | $28.00 |
| Sep 2, 2026 | Mizuho | Maintained | Outperform | $26.00 |
| Sep 2, 2026 | UBS | Maintained | Buy | $28.00 |
| Sep 2, 2026 | Wells Fargo | Maintained | Overweight | $26.00 |
| Sep 2, 2026 | Evercore ISI Group | Maintained | Outperform | $27.00 |
| Sep 2, 2026 | Citigroup | Maintained | Buy | $26.00 |
| Sep 1, 2026 | BTIG | Maintained | Buy | $28.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Buy | $25.00 |
| Jun 4, 2026 | Wells Fargo | Maintained | Overweight | $22.00 |
| May 18, 2026 | B of A Securities | Maintained | Buy | $20.00 |
| May 12, 2026 | Benchmark | Initiated Coverage | Buy | $20.00 |
| Apr 1, 2026 | Barclays | Initiated Coverage | Overweight | $26.00 |
| Mar 31, 2026 | Mizuho | Initiated Coverage | Outperform | $21.00 |
| Mar 31, 2026 | Piper Sandler | Initiated Coverage | Neutral | $16.00 |
| Mar 31, 2026 | Evercore ISI Group | Initiated Coverage | Outperform | $20.00 |

## Frequently Asked Questions

### What is the price target for MMED stock?

The average 12-month analyst price target for MiniMed Group (MMED) is $25.91, with a high estimate of $29.00 and a low of $21.00, across 11 analysts.

### Is MMED a buy, sell, or hold?

Analysts covering MiniMed Group currently average a Buy rating: 12 buy, 3 hold and 1 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for MMED?

The average price target of $25.91 implies 43.94% upside from the last price of $18.00.

### What is the latest analyst rating on MMED?

On Oct 12, 2026, Jefferies initiated coverage of MiniMed Group at Hold with a price target of $22.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).